Policy Lead
US Food & Drug Administration
Martina Sahre, PhD is a Policy Lead in the Office of Clinical Pharmacology (OCP), Food and Drug Administration (FDA). Martina received her PhD from the University of Florida. In her current role she contributes to regulatory policy development and regulatory research focused on intrinsic factors. Prior to this role, she was a Reviewer in the Cardiovascular and Renal Products team in OCP, conducting regulatory review of investigational new drug (IND), new drug (NDA), and biologic licensing applications (BLA).
Disclosure information not submitted.
Symposium 9: Rethinking Hepatic Impairment Studies: A Patient-centric Approach
Monday, September 9, 2024
3:30 PM – 5:00 PM ET
2 - Informing Appropriate Dosing in Target Populations
Monday, September 9, 2024
3:30 PM – 5:00 PM ET